comparemela.com

Latest Breaking News On - Oncologic sciences - Page 1 : comparemela.com

Dr Eroglu on Addressing Unmet Needs in Mutant Melanoma

Zeynep Eroglu, MD, discusses a phase 1/2 trial that evaluated ceritinib alone and in combination with trametinib in patients with mutant melanoma.

Zeynep erogluMoffitt cancer centerDepartment of oncologic sciencesDepartment of cutaneous oncologyCutaneous oncologyOncologic sciencesSouth florida morsani collegeMoffitt cancer centerMelanoma amp skin cancerOnclive tv

Dr Eroglu on Ceritinib With or Without Trametinib in Pretreated Advanced Melanoma

Zeynep Eroglu, MD, discusses the efficacy and safety of ceritinib as monotherapy and in combination with trametinib in pretreated advanced melanoma.

Zeynep erogluDepartment of cutaneous oncologyMoffitt cancer centerDepartment of oncologic sciencesCutaneous oncologyOncologic sciencesSouth florida morsani collegePretreated advanced melanoma

Comprehensive Review Highlights Potential Benefits of Leukine® in Management of Gastrointestinal (GI) Adverse Events Associated with Immune Checkpoint Inhibitors (ICIs) in the Treatment of Cancer

NCI sponsored, ECOG-ACRIN Phase 3 Study of Leukine in Combination with Ipilimumab and Nivolumab in Front Line Treatment of Melanoma Heads to Last Stages of Enrollment

United statesDana farber cancer instituteAhmada tarhiniF stephen hodi jrH lee moffitt cancer centerProfessor of oncologic sciencesMelanoma committeeTanner pharma groupPrnewswire partner therapeutics incClinical translational researchNational cancer institutePartner therapeutics incOncology at dana farber cancer instituteResearch instituteStudy coCancer research group

Toxicities Hinder Potential Efficacy of Ceritinib/Trametinib in Pretreated Advanced Melanoma

Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma.

Zeynep erogluKeiran smalleyMoffitt cancer centerDepartment of oncologic sciencesCutaneous oncologyOncologic sciencesSouth florida morsani collegeCeritinib and trametinib

Dr Eroglu on the Safety Profile of Ceritinib Plus Trametinib in Advanced Melanoma

Zeynep Eroglu, MD, discusses the safety profile of ceritinib plus trametinib in pretreated metastatic melanoma.

Zeynep erogluUniversity of south floridaMoffitt cancer centerDepartment of oncologic sciencesDepartment of cutaneous oncologyMorsani college of medicineCutaneous oncologyOncologic sciencesSouth floridaMorsani collegeSkin cancerOnclive tvCeritinib plus trametinib

vimarsana © 2020. All Rights Reserved.